[go: up one dir, main page]

TNSN94099A1 - Nouvelles compositions d'emulsions - Google Patents

Nouvelles compositions d'emulsions

Info

Publication number
TNSN94099A1
TNSN94099A1 TNTNSN94099A TNSN94099A TNSN94099A1 TN SN94099 A1 TNSN94099 A1 TN SN94099A1 TN TNSN94099 A TNTNSN94099 A TN TNSN94099A TN SN94099 A TNSN94099 A TN SN94099A TN SN94099 A1 TNSN94099 A1 TN SN94099A1
Authority
TN
Tunisia
Prior art keywords
emulsion compositions
new emulsion
optionally
water
present
Prior art date
Application number
TNTNSN94099A
Other languages
English (en)
Inventor
Lundquist Stefan
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of TNSN94099A1 publication Critical patent/TNSN94099A1/fr

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENTION PORTE SUR UNE COMPOSITION PHARMACEUTIQUE SOUS LA FORME D'UNE EMULSION D'HUILE DANS DE L'EAU DESTINEE A l'ADMINISTRATION PAR VOIE PARENTERALE OU BUCCALE ET COMPRENANT : (i) UN MEDICAMENT TENSIO-ACTIF, STABILISATEUR DE SURFACE, PRESENT EN CONCENTRATION ELEVEE ; (ii) OPTIONNELLEMENT UNE HUILE PHARMACEUTIQUEMENT INERTE ; (iii) OPTIONNELLEMENT UN SURFACTANT ; (iv) DE L'EAU OU UN TAMPON ; ET (v) UN AGENT RENDANT LA SOLUTION FINALE ISOTONIQUE ; UN PROCEDE ET L'EMPLOI D'UN PROCEDE POUR LA PREPARATION DE LA COMPOSITION
TNTNSN94099A 1993-10-07 1994-10-07 Nouvelles compositions d'emulsions TNSN94099A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9303281A SE9303281D0 (sv) 1993-10-07 1993-10-07 New formulation

Publications (1)

Publication Number Publication Date
TNSN94099A1 true TNSN94099A1 (fr) 1995-04-25

Family

ID=20391342

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN94099A TNSN94099A1 (fr) 1993-10-07 1994-10-07 Nouvelles compositions d'emulsions

Country Status (30)

Country Link
US (2) US5843465A (fr)
EP (1) EP0722316B1 (fr)
JP (1) JPH09504279A (fr)
CN (1) CN1134663A (fr)
AT (1) ATE189119T1 (fr)
AU (1) AU701512B2 (fr)
BR (1) BR9407748A (fr)
CA (1) CA2172143A1 (fr)
CZ (1) CZ94396A3 (fr)
DE (1) DE69422818T2 (fr)
DK (1) DK0722316T3 (fr)
EE (1) EE03235B1 (fr)
EG (1) EG20540A (fr)
ES (1) ES2145158T3 (fr)
FI (1) FI961525A7 (fr)
GR (1) GR3033255T3 (fr)
HU (1) HUT74638A (fr)
IL (1) IL111131A (fr)
IS (1) IS4209A (fr)
MA (1) MA23344A1 (fr)
NO (1) NO961363L (fr)
NZ (1) NZ274583A (fr)
PL (1) PL313767A1 (fr)
PT (1) PT722316E (fr)
SE (1) SE9303281D0 (fr)
SG (1) SG47896A1 (fr)
SK (1) SK39396A3 (fr)
TN (1) TNSN94099A1 (fr)
WO (1) WO1995009609A1 (fr)
ZA (1) ZA947351B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US6281175B1 (en) 1997-09-23 2001-08-28 Scimed Life Systems, Inc. Medical emulsion for lubrication and delivery of drugs
US6054421A (en) * 1997-09-23 2000-04-25 Scimed Life Systems, Inc. Medical emulsion lubricant
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
WO2000010531A1 (fr) 1998-08-19 2000-03-02 Rtp Pharma Inc. Dispersions aqueuses injectables de propofol
US20020086857A1 (en) * 2000-09-15 2002-07-04 Mcdonald George B. Method of long-term treatment of graft-versus-host disease using topical active corticosterioids
US20100184732A1 (en) * 2000-09-15 2010-07-22 Mcdonald George Method of long-term treatment of graft-versus-host disease using topical active corticosteroids
DE10059430A1 (de) * 2000-11-30 2002-06-06 Cognis Deutschland Gmbh Feinteilige Emulsionen
US7387790B2 (en) 2001-06-15 2008-06-17 Cornerstone Pharmaceuticals Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells
DE60220923T2 (de) * 2001-08-06 2008-03-06 Astrazeneca Ab Wässrige dispersion stabiler nanopartikel eines wasserunlöslichen wirkstoffs und ein hilfsstoff wie mittelkettige triglyceride (mct)
TWI248159B (en) * 2002-01-25 2006-01-21 Nanya Technology Corp Manufacturing method for shallow trench isolation with high aspect ratio
GB0216700D0 (en) * 2002-07-18 2002-08-28 Astrazeneca Ab Process
US7544674B2 (en) 2002-10-25 2009-06-09 Galderma S.A. Topical skin care composition
US8685428B2 (en) * 2002-12-10 2014-04-01 Advanced Cardiovascular Systems, Inc. Therapeutic composition and a method of coating implantable medical devices
GB0230088D0 (en) * 2002-12-24 2003-01-29 Astrazeneca Ab Therapeutic agents
GB0230087D0 (en) * 2002-12-24 2003-01-29 Astrazeneca Ab Therapeutic agents
GB0302671D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
GB0302673D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
GB0302672D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
US7323206B1 (en) 2003-03-04 2008-01-29 B. Braun Medical Inc. Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
GB0314057D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
JP2006527770A (ja) * 2003-06-18 2006-12-07 アストラゼネカ アクチボラグ Ｃｂ１モジュレーターとしての２−置換５，６−ジアリール−ピラジン誘導体
GB0314261D0 (en) * 2003-06-19 2003-07-23 Astrazeneca Ab Therapeutic agents
WO2005009406A1 (fr) * 2003-07-18 2005-02-03 Hill Dermaceuticals, Inc. Composition topique de soins de la peau contenant de l'huile de cacahuetes raffinee
US20070140999A1 (en) * 2003-07-18 2007-06-21 Hill Dermaceuticals, Inc. Topical skin care composition containing refined peanut oil
US20060099173A1 (en) * 2003-10-24 2006-05-11 Nancy Puglia Topical skin care composition
US20070207107A1 (en) * 2006-03-03 2007-09-06 Gareth Winckle Silicone based emulsions for topical drug delivery
US8473062B2 (en) 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US9320908B2 (en) 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4073943A (en) * 1974-09-11 1978-02-14 Apoteksvarucentralen Vitrum Ab Method of enhancing the administration of pharmalogically active agents
AT358530B (de) * 1978-04-25 1980-09-10 Plc Pharma Licences Stabilisierungsverfahren
JPS58222014A (ja) * 1982-06-18 1983-12-23 Taisho Pharmaceut Co Ltd プロスタグランジンｅ↓１脂肪乳剤
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
JPH0818989B2 (ja) * 1984-01-12 1996-02-28 株式会社ミドリ十字 脂肪乳剤中のプロスタグランジンの安定化方法
JPH0647533B2 (ja) * 1984-08-10 1994-06-22 裕 水島 ４−ビフエニリル酢酸系化合物含有脂肪乳剤
US4760096A (en) * 1985-09-27 1988-07-26 Schering Corporation Moisturizing skin preparation
DE3623376A1 (de) * 1986-07-11 1988-01-21 Behringwerke Ag Pharmazeutische formulierung und verfahren zu deren herstellung
GB8919172D0 (en) * 1989-08-23 1989-10-04 Univ Nottingham Useful composition
JP2785981B2 (ja) * 1989-11-20 1998-08-13 株式会社資生堂 乳化組成物
US5089268A (en) * 1990-05-02 1992-02-18 Katz David P Egg phosphatide lipid emulsions altered for a specific therapeutic fatty acid composition

Also Published As

Publication number Publication date
US5660837A (en) 1997-08-26
NO961363D0 (no) 1996-04-02
MA23344A1 (fr) 1995-07-01
NZ274583A (en) 1998-01-26
PL313767A1 (en) 1996-07-22
PT722316E (pt) 2000-06-30
US5843465A (en) 1998-12-01
HK1009257A1 (en) 1999-05-28
ATE189119T1 (de) 2000-02-15
EP0722316B1 (fr) 2000-01-26
IS4209A (is) 1995-04-08
AU701512B2 (en) 1999-01-28
HUT74638A (en) 1997-01-28
AU7866794A (en) 1995-05-01
IL111131A0 (en) 1994-12-29
DK0722316T3 (da) 2000-06-13
IL111131A (en) 1999-09-22
NO961363L (no) 1996-04-02
BR9407748A (pt) 1997-11-11
EG20540A (en) 1999-07-31
DE69422818D1 (de) 2000-03-02
GR3033255T3 (en) 2000-09-29
HU9600900D0 (en) 1996-05-28
DE69422818T2 (de) 2000-07-27
SG47896A1 (en) 1998-04-17
FI961525A0 (fi) 1996-04-04
SE9303281D0 (sv) 1993-10-07
WO1995009609A1 (fr) 1995-04-13
CA2172143A1 (fr) 1995-04-13
CN1134663A (zh) 1996-10-30
ES2145158T3 (es) 2000-07-01
CZ94396A3 (en) 1996-06-12
FI961525L (fi) 1996-04-04
EP0722316A1 (fr) 1996-07-24
ZA947351B (en) 1995-04-10
JPH09504279A (ja) 1997-04-28
FI961525A7 (fi) 1996-04-04
SK39396A3 (en) 1997-02-05
EE03235B1 (et) 1999-12-15

Similar Documents

Publication Publication Date Title
TNSN94099A1 (fr) Nouvelles compositions d'emulsions
KR950031069A (ko) 골손실의 억제 및 혈청 콜레스테롤의 강하 방법
DZ2666A1 (fr) Dérivés d'acide hydroxamique compositions pharmaceutiques les contenant et procédé pour leur préparation.
TNSN96075A1 (fr) N-(indole-2-carbonyl) - beta- alaninamides substitues et leurs derives, servant d'agents antidiabetiques
FR2735978B1 (fr) Composition pharmaceutique d'amiodarone pour administration parenterale
ATE109659T1 (de) Arzneimittelzusammensetzungen.
BE899635A (fr) Compositions pharmaceutiques.
MA26586A1 (fr) Association pharmaceutique pour le traitement d'un dysfonctionnement sexuel et compositions la contenant
BR9706537A (pt) Composição farmacêutica para administração por via oral
DZ2550A1 (fr) Dérivés d'azétidinylpropylpipéridine procédé pour leur préparation et compositions pharmaceutiques les contenant.
BE900564A (fr) Composition pharmaceutique pour le traitement d'arteriopathies peripheriques.
DZ2717A1 (fr) Dérivés d'acide dihydroxyhexanoïque nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
ATE153342T1 (de) Adenosinderivate, verfahren zu deren herstellung und pharmazeutische mittel
DZ1324A1 (fr) Dérivés de céphalosporine, procédé pour leur préparation compositions pharmaceutiques les contenant et leur utilisation dans le traitement d'infections bactériennes.
MC2280A1 (fr) Derives de galactomannanes utilisables pour le revetement ou l'enrobage de substances actives de medicaments
MA26744A1 (fr) Polymorphes d'un chlorhydrate d'azo-bicyclo-2,2,2-oct-3-ylamine cristallins et compositions pharmaceutiques les contenant
MA27980A1 (fr) Nouvelle composition
KR890012942A (ko) 5-치환된 오르니틴 유도체
BE904846A (fr) Steroides 11beta-substitues utiles notamment dans le traitement des tumeurs hormono-dependantes et procede pour la fabrication.
KR880004810A (ko) 소화성 궤양 치료제
EP0129891A3 (fr) Dérivés de quinazolinone, procédés pour leur préparation et compositions pharamceutiques les comprenant
FR2604903B1 (fr) Agents therapeutiques sous forme de particules submicroscopiques contre des parasitoses et compositions pharmaceutiques les contenant
KR910009255A (ko) 과트리글리세라이드혈증과, 콜레스테롤혈증, 저레벨의 hdl질환 및 아테롬성 동맥경화증 치료제로서 사용되는 2-(페녹시 프로파놀아미노)에톡시 페녹시아세트산 유도체
FR2374036A1 (fr) Compositions pharmaceutiques contenant de la 3-phenoxypyridine
KR910011258A (ko) 녹내장의 치료방법